As per the analysts and healthcare investors, it is being predicted that drug-makers Pfizer Inc, Moderna Inc, BioNTech will reap billions of dollars from the Covid-19 booster shots, in the annual sales of flu vaccine markets that could rival $6 billion in a year.
For many months these drug-maker companies have been saying, that people who are vaccinated will need an extra dose of vaccine to keep the protection from new variants of the Corona Virus. A list of countries like Chile, Germany, and Israel has already decided to give a booster dose to their older citizens and people with a weak immune system especially, when a fast spread of delta variant has become a sign of concern. The United Kingdom and the United States are also preparing to follow the same pattern.
Keeping this in mind Pfizer with its German partner BioNTech, and Moderna have already locked up over $60 billion in sales of vaccine shots for the years 2021 and 2022. This agreement consist supply of the first two doses of vaccine and well as billions of dollars in potential boosters for the wealthy nations.